Los Angeles Capital Management
AMED

Los Angeles Capital Management’s Amedisys AMED Stock Holding History

Los Angeles Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,821
Closed -$570K – 1386
2021
Q3 		$570K Sell
3,821
-432
-10% -$89.8K ﹤0.01% 993
2021
Q2 		$1.04M Sell
4,253
-360
-8% -$94.5K ﹤0.01% 838
2021
Q1 		$1.22M Sell
4,613
-2,586
-36% -$729K 0.01% 807
2020
Q4 		$2.11M Sell
7,199
-326
-4% -$83.6K 0.01% 643
2020
Q3 		$1.78M Sell
7,525
-10,609
-59% -$2.41M 0.01% 602
2020
Q2 		$3.6M Sell
18,134
-6,336
-26% -$1.18M 0.02% 470
2020
Q1 		$4.49M Buy
24,470
+1,431
+6% +$255K 0.03% 365
2019
Q4 		$3.85M Buy
23,039
+5,726
+33% +$852K 0.02% 481
2019
Q3 		$2.27M Buy
17,313
+100
+0.6% +$13K 0.01% 597
2019
Q2 		$2.09M Sell
17,213
-4,400
-20% -$522K 0.01% 628
2019
Q1 		$2.66M Sell
21,613
-2,820
-12% -$354K 0.01% 579
2018
Q4 		$2.86M Sell
24,433
-4,310
-15% -$508K 0.02% 472
2018
Q3 		$3.59M Sell
28,743
-8,830
-24% -$975K 0.02% 517
2018
Q2 		$3.21M Sell
37,573
-21,330
-36% -$1.57M 0.02% 576
2018
Q1 		$3.55M Sell
58,903
-16,150
-22% -$920K 0.02% 500
2017
Q4 		$3.96M Buy
75,053
+31,584
+73% +$1.66M 0.02% 499
2017
Q3 		$2.43M Buy
43,469
+21,850
+101% +$1.16M 0.01% 569
2017
Q2 		$1.36M Buy
+21,619
New +$1.26M 0.01% 689
2014
Q3 		– Sell
-19,931
Closed -$334K – 1069
2014
Q2 		$334K Buy
19,931
+6,800
+52% +$96.4K ﹤0.01% 1002
2014
Q1 		$196K Buy
+13,131
New +$202K ﹤0.01% 1194
2013
Q4 		– Sell
-52,895
Closed -$910K – 1271
2013
Q3 		$910K Sell
52,895
-1,375
-3% -$20.4K 0.01% 702
2013
Q2 		$630K Buy
+54,270
New +$622K 0.01% 828

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Los Angeles Capital Management's AMED Position: Q4 2021 in Review

Los Angeles Capital Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 3,821 shares — an estimated $570K sold.

Los Angeles Capital Management first reported a position in AMED in Q2 2013 and held it in 22 quarters. The position peaked at $4.49M in Q1 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Los Angeles Capital Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 3,821 Amedisys shares in Q4 2021, an estimated $570K.
  • Los Angeles Capital Management first reported a position in Amedisys in Q2 2013 and held it in 22 quarters.
  • Los Angeles Capital Management's Amedisys position peaked at $4.49M in Q1 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Los Angeles Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.